Correlation Between BioAffinity Technologies, and HTG Molecular

Can any of the company-specific risk be diversified away by investing in both BioAffinity Technologies, and HTG Molecular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioAffinity Technologies, and HTG Molecular into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between bioAffinity Technologies, and HTG Molecular Diagnostics, you can compare the effects of market volatilities on BioAffinity Technologies, and HTG Molecular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioAffinity Technologies, with a short position of HTG Molecular. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioAffinity Technologies, and HTG Molecular.

Diversification Opportunities for BioAffinity Technologies, and HTG Molecular

0.58

Correlation Coefficient

BioAffinity Technologies,  HTG Molecular

Very weak diversification

The 3 months correlation between BioAffinity and HTG is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding bioAffinity Technologies, and HTG Molecular Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HTG Molecular Diagnostics and BioAffinity Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on bioAffinity Technologies, are associated (or correlated) with HTG Molecular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HTG Molecular Diagnostics has no effect on the direction of BioAffinity Technologies, i.e., BioAffinity Technologies, and HTG Molecular go up and down completely randomly.

Pair Corralation between BioAffinity Technologies, and HTG Molecular

If you would invest  57.00  in HTG Molecular Diagnostics on August 31, 2024 and sell it today you would earn a total of  0.00  from holding HTG Molecular Diagnostics or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	1.59%
Values	Daily Returns

bioAffinity Technologies,  vs.  HTG Molecular Diagnostics

bioAffinity Technologies,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days bioAffinity Technologies, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BioAffinity Technologies, is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

HTG Molecular Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HTG Molecular Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, HTG Molecular is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with BioAffinity Technologies, and HTG Molecular

The main advantage of trading using opposite BioAffinity Technologies, and HTG Molecular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioAffinity Technologies, position performs unexpectedly, HTG Molecular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HTG Molecular will offset losses from the drop in HTG Molecular's long position.

The idea behind bioAffinity Technologies, and HTG Molecular Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.